The treatment of osteoarthritis with new injectable cells may be successful.

Published Date: 26 Apr 2023

Researchers from the Wake Forest Institute for Regenerative Medicine (WFIRM) have developed a promising injectable cell therapy for osteoarthritis that not only lowers inflammation but also regenerates articular cartilage.

Read Full News

Latest News

OA Trial Drug Seeks to Be Analgesic Alternative to NSAIDs

If future trials continue to show positive results, the drug may provide a pain-relief option that lacks the risks of long-term NSAID use.

10-Year Data Confirm No Benefit From Knee Arthroscopy

Ten-year follow-up data from the FIDELITY sham knee arthroscopy study confirms the procedure offers no benefits and may be associated with worse outcomes.

PT Beats CBT for First-Line Low Back Pain Treatment

Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy.

Do Palindromic Flares Indicate Future Arthritis Joint Sites?

Palindromic rheumatism often begins with hand and shoulder involvement, and patients who progress to persistent inflammatory arthritis develop it in joints affected by prior palindromic flares.

Prescribing Walks Wisely in Low Back Pain

Individualized walking programs can reduce recurrent, disabling low back pain, but clinicians should screen for lower extremity biomechanical vulnerabilities and favor low impact options when needed.

Winter Sports and Lower Limb Motor Disability

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Latest News

If future trials continue to show positive results, the drug may provide a pain-relief option that lacks the risks of long-term NSAID use.

Ten-year follow-up data from the FIDELITY sham knee arthroscopy study confirms the procedure offers no benefits and may be associated with worse outcomes.

Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy.

Palindromic rheumatism often begins with hand and shoulder involvement, and patients who progress to persistent inflammatory arthritis develop it in joints affected by prior palindromic flares.

Individualized walking programs can reduce recurrent, disabling low back pain, but clinicians should screen for lower extremity biomechanical vulnerabilities and favor low impact options when needed.

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

News All Time

Walking, cycling and swimming are likely the best exercises for knee osteoarthritis

For patients with knee osteoarthritis, aerobic activities such as walking, cycling, or swimming are likely to be the best exercise for improving pain, function, gait performance, and quality of life, finds a study published ...

SGLT-2 diabetes drugs linked to lower risk of autoimmune diseases

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, compared with another group ...

Arthritis pain rising: How state policies matter

New research from The University of Texas at Arlington shows that differences in state welfare policies are linked to rising arthritis-related joint pain across much of the U.S.

Customizable finger brace toggles between stiff and flexible for easier recovery

A friend's struggles with arthritis and the finger braces used to manage it inspired research by a Carnegie Mellon University student that could make it easier for patients to follow rehabilitation plans, speed up recovery ...

AI predicts future X-rays to help osteoarthritis patients and their doctors see what's coming

An AI system that can predict what a patient's knee X-ray will look like a year in the future could transform how millions of people with osteoarthritis understand and manage their condition, according to research by the ...

Joint pain or osteoarthritis? Exercise could be the first line of treatment

Stiff knees, aching hips and the slow grind of chronic joint pain are often accepted as an unavoidable part of getting older. But while osteoarthritis is the world's most common joint disease, experts say the way we treat ...

Study finds tailored exercise program feasible for adults over 80 with osteoarthritis

A new NDORMS study has found that a tailored exercise program for people aged 80 years and older with hip and/or knee osteoarthritis and other long term health conditions is both practical and acceptable, paving the way for ...

New treatment for psoriatic arthritis shows promising results in early trial

A new treatment for a debilitating inflammatory condition which affects joints and skin has shown promising early results in an international clinical trial of more than 200 patients worldwide.

Seven-year study reveals rheumatoid arthritis begins long before symptoms, opening door to prevention 

Scientists have discovered that rheumatoid arthritis (RA) doesn't start when the pain begins. It silently starts years earlier. RA is a debilitating autoimmune disease that causes painful joint inflammation and damage. The ...

Self-guided online program improves quality of life in rheumatoid arthritis, psoriatic arthritis and lupus

Patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus frequently face anxiety and depression along with chronic physical symptoms. Reported rates of depression range from 15% to 24% and ...

Analysis isolates population aging as primary driver of musculoskeletal disorders

Novel research shows that in approximately one third of countries and territories worldwide, population aging was the largest contributor to the growing burden of musculoskeletal disorders from 1990 to 2021.

Tirzepatide found to be more cost-effective than semaglutide in patients with knee osteoarthritis, obesity

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and obesity compared with usual ...

Current research may open doors to new treatments for children with juvenile dermatomyositis

Children with a rare, debilitating muscle disease could benefit from the findings of new research by experts at UCL and Great Ormond Street Hospital (GOSH).

Squishy 'smart cartilage' could target arthritis pain as soon as flareups begin

Researchers have developed a material that can sense tiny changes within the body, such as during an arthritis flareup, and release drugs exactly where and when they are needed.

Immune aging may be a driver of rheumatoid arthritis rather than a consequence

Features of immune system aging can be detected in the earliest stages of rheumatoid arthritis (RA), even before clinical diagnosis, a new study has found which provides at-risk individuals with hope for early intervention.

Common arthritis drug found to lower blood pressure and risk of heart disease

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in people with this condition.

Recommended News For You

Prior authorizations draining time, energy from many cancer patients

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

Regular physical activity before cancer diagnosis may lower progression and death risks

combating racial discrimination in next-generation breast cancer screening.

A new theranostic drug targets different cancer types.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Recommended Articles For You

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Unmasking the Subtle Symptoms of Colon Cancer 

Survival Rates in Cancer: Focus on Acute Myeloid Leukemia and Other Malignancies 

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035

2.

When Should Immunocompromised Individuals Receive a COVID Booster?

3.

Novel biomarker has potential for predicting and treating skin cancer metastasis

4.

Taking Charge of Your Cancer Journey.

5.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

1.

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection

2.

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025

3.

Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy

4.

Cowden Syndrome and Cancer: Understanding the Risk Factors 

5.

Cemiplimab: A Revolutionary Drug For Treating Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

2.

Efficient Management of First line ALK-rearranged NSCLC

3.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

5.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot